VAMP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.937430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.245200E-01
Normal-vs-Stage2
1.002360E-01
Normal-vs-Stage3
1.188410E-01
Normal-vs-Stage4
6.188000E-01
Stage1-vs-Stage2
1.342550E-01
Stage1-vs-Stage3
5.961800E-02
Stage1-vs-Stage4
7.549200E-01
Stage2-vs-Stage3
1.643200E-01
Stage2-vs-Stage4
4.493800E-01
Stage3-vs-Stage4
1.483420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.888840E-01
Normal-vs-AfricanAmerican
5.578400E-01
Normal-vs-Asian
3.080200E-01
Caucasian-vs-AfricanAmerican
3.679000E-01
Caucasian-vs-Asian
9.667600E-01
AfricanAmerican-vs-Asian
6.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.449030E-01
Normal-vs-Female
2.882600E-01
Male-vs-Female
3.154400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.127600E-01
Normal-vs-Age(41-60Yrs)
3.767600E-01
Normal-vs-Age(61-80Yrs)
1.421040E-01
Normal-vs-Age(81-100Yrs)
2.978000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.714600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.051200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.295200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.306200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.370000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.235600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.145600E-02
Normal-vs-Daily Drinker
3.193800E-01
Normal-vs-Weekly Drinker
3.474200E-01
Normal-vs-Occasional Drinker
6.331400E-01
Normal-vs-Social Drinker
7.340600E-01
Non Drinker-vs-Daily Drinker
1.925040E-01
Non Drinker-vs-Weekly Drinker
8.610800E-01
Non Drinker-vs-Occasional Drinker
2.981700E-02
Non Drinker-vs-Social Drinker
3.332600E-01
Daily Drinker-vs-Weekly Drinker
3.745600E-01
Daily Drinker-vs-Occasional Drinker
2.804500E-03
Daily Drinker-vs-Social Drinker
1.403580E-01
Weekly Drinker-vs-Occasional Drinker
2.166200E-01
Weekly Drinker-vs-Social Drinker
4.786000E-01
Occasional Drinker-vs-Social Drinker
8.829600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.646100E-02
Normal-vs-Grade 2
9.816000E-04
Normal-vs-Grade 3
1.298080E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.630000E-01
Grade 1-vs-Grade 3
4.003800E-01
Grade 1-vs-Grade 4
4.646100E-02
Grade 2-vs-Grade 3
7.624400E-01
Grade 2-vs-Grade 4
9.816000E-04
Grade 3-vs-Grade 4
1.298080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.214800E-01
Normal-vs-NonDiabetic
2.168200E-01
Diabetic-vs-NonDiabetic
2.776800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.279800E-01
Normal-vs-NoPancreatitis
2.173000E-01
Pancreatitis-vs-NoPancreatitis
2.888500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.190800E-01
Normal-vs-N1
8.081900E-02
N0-vs-N1
6.132300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.202400E-01
Normal-vs-TP53-NonMutant
6.401200E-01
TP53-Mutant-vs-TP53-NonMutant
9.137900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
